Compare ITUB & COR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ITUB | COR |
|---|---|---|
| Founded | 1924 | 2001 |
| Country | Brazil | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Other Pharmaceuticals |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 81.4B | 68.5B |
| IPO Year | N/A | N/A |
| Metric | ITUB | COR |
|---|---|---|
| Price | $8.99 | $359.25 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 13 |
| Target Price | $7.77 | ★ $391.31 |
| AVG Volume (30 Days) | ★ 28.7M | 1.3M |
| Earning Date | 02-04-2026 | 02-04-2026 |
| Dividend Yield | ★ 8.06% | 0.67% |
| EPS Growth | 13.27 | ★ 18.64 |
| EPS | 0.74 | ★ 8.33 |
| Revenue | $25,400,232,630.00 | ★ $325,777,775,000.00 |
| Revenue This Year | $39.16 | $7.19 |
| Revenue Next Year | $7.43 | $6.19 |
| P/E Ratio | ★ $11.59 | $43.12 |
| Revenue Growth | N/A | ★ 7.45 |
| 52 Week Low | $4.73 | $237.71 |
| 52 Week High | $9.11 | $377.54 |
| Indicator | ITUB | COR |
|---|---|---|
| Relative Strength Index (RSI) | 66.30 | 52.37 |
| Support Level | $8.37 | $328.01 |
| Resistance Level | $8.99 | $362.35 |
| Average True Range (ATR) | 0.22 | 10.29 |
| MACD | 0.03 | -0.55 |
| Stochastic Oscillator | 82.51 | 67.02 |
Itau Unibanco is the largest privately held bank in Brazil, the result of the 2008 merger between Banco Itau and Unibanco. In addition to Brazil, the bank has significant operations in Chile, Colombia, Argentina, Uruguay, and Paraguay. Itau's commercial and consumer loans account for 35% and 43% of the bank's total loans, respectively, while foreign loans account for 22% of its portfolio. The bank also operates the fifth-largest insurer in Brazil and is the second-largest asset manager in the country, giving it broad reach over the Brazilian financial system.
Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health hold over 90% share of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.